Alterations in protein phosphorylation in the amygdala of the 5XFamilial Alzheimer's disease animal model

Alterations in protein phosphorylation in the amygdala of the 5XFamilial Alzheimer's disease animal model

Alzheimer's disease is the most common disease underlying dementia in humans. Two major neuropathological hallmarks of AD are neuritic plaques primarily composed of amyloid beta peptide and neurofibrillary tangles primarily composed of hyperphosphorylated tau. In addition to impaired memory fun...

Full description

Bibliographic Details
Main Authors:	Eun-Jeong Yang, Usman Mahmood, Hyunju Kim, Moonseok Choi, Yunjung Choi, Jean-Pyo Lee, Moon-Jeong Chang, Hye-Sun Kim
Format:	Article
Language:	English
Published:	Elsevier 2017-04-01
Series:	Journal of Pharmacological Sciences
Subjects:	Alzheimer's disease Amygdala Cued fear conditioning 5XFamilial Alzheimer's disease mice Protein phosphorylation
Online Access:	http://www.sciencedirect.com/science/article/pii/S1347861317300452

Similar Items

Inhibition of STAT3 phosphorylation attenuates impairments in learning and memory in 5XFAD mice, an animal model of Alzheimer's disease
by: Moonseok Choi, et al.
Published: (2020-08-01)

Rosiglitazone reduces tau phosphorylation via JNK inhibition in the hippocampus of rats with type 2 diabetes and tau transfected SH-SY5Y cells
by: Seung-Yong Yoon, et al.
Published: (2010-11-01)

Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau
by: Kevin H. Strang, et al.
Published: (2017-07-01)

Early amygdala and ERC atrophy linked to 3D reconstruction of rostral neurofibrillary tau tangle pathology in Alzheimer’s disease
by: Kaitlin M. Stouffer, et al.
Published: (2023-01-01)

Inhibitory networks of the amygdala for emotional memory
by: Seungho eLee, et al.
Published: (2013-08-01)

The importance of tau phosphorylation for neurodegenerative diseases
by: Wendy eNoble, et al.
Published: (2013-07-01)

7T amygdala and hippocampus subfields in volumetry-based associations with memory: A 3-year follow-up study of early Alzheimer’s disease
by: Laura Göschel, et al.
Published: (2023-01-01)

Disruption of the astrocyte–neuron interaction is responsible for the impairments in learning and memory in 5XFAD mice: an Alzheimer’s disease animal model
by: Moonseok Choi, et al.
Published: (2021-07-01)

A Critical Evaluation of the Claim that the Amygdala's Primary Function in Social Perception is in Underpinning the Perception and Experience of Fear
by: Liam Alexander MacKenzie Myles
Published: (2022-04-01)

The peptidyl prolyl cis/trans isomerase Pin1/Ess1 inhibits phosphorylation and toxicity of tau in a yeast model for Alzheimer’s disease
by: Ann De Vos, et al.
Published: (2015-04-01)

Protein phosphorylation in neurodegeneration: friend or foe?
by: Sandra eTenreiro, et al.
Published: (2014-05-01)

Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease
by: Robert Y. K. Lai, et al.
Published: (2016-04-01)

Intravenously Injected Amyloid-β Peptide With Isomerized Asp7 and Phosphorylated Ser8 Residues Inhibits Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice Model of Alzheimer’s Disease
by: Sergey A. Kozin, et al.
Published: (2018-08-01)

Understanding Emotions: Origins and Roles of the Amygdala
by: Goran Šimić, et al.
Published: (2021-05-01)

Protein phosphatase 2A dysfunction in Alzheimer’s disease
by: Jean-Marie eSontag, et al.
Published: (2014-03-01)

Oxytocin Promotes Accurate Fear Discrimination and Adaptive Defensive Behaviors
by: Valentina Olivera-Pasilio, et al.
Published: (2020-09-01)

Plasticity of fear and safety neurons of the amygdala in response to fear extinction
by: Susan eSangha, et al.
Published: (2015-12-01)

Asymmetry of Hippocampus and Amygdala Defect in Subjective Cognitive Decline Among the Community Dwelling Chinese
by: Ling Yue, et al.
Published: (2018-06-01)

Association Between Amygdala Volume and Trajectories of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia With Lewy Bodies
by: Alberto Jaramillo-Jimenez, et al.
Published: (2021-07-01)

Identification and Characterization of GABAergic Projection Neurons from Ventral Hippocampus to Amygdala
by: Robert Lübkemann, et al.
Published: (2015-07-01)

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum
by: Johan Gobom, et al.
Published: (2022-12-01)

Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology
by: Shengnan Zhang, et al.
Published: (2022-09-01)

Induction of Zenk protein expression within the nucleus taeniae of the amygdala of pigeons following tone and shock stimulation
by: I. Brito, et al.
Published: (2011-08-01)

Induction of Zenk protein expression within the nucleus taeniae of the amygdala of pigeons following tone and shock stimulation
by: I. Brito, et al.
Published: (2011-08-01)

Phloroglucinol attenuates oligomeric amyloid beta peptide1-42-induced astrocytic activation by reducing oxidative stress
by: Eun-Jeong Yang, et al.
Published: (2021-04-01)

Optogenetic dissection of amygdala functioning
by: Ryan eLalumiere
Published: (2014-03-01)

Neuronal Plasticity in the Amygdala Following Predator Stress Exposure
by: Rupshi Mitra
Published: (2019-02-01)

Controllable Stress Increases Rapid Eye Movement Sleep in Rats: Regulation by the Central Nucleus of the Amygdala
by: Laurie L. Wellman, et al.
Published: (2023-07-01)

Infusions of AP5 into the basolateral amygdala impair the formation, but not the expression, of step-down inhibitory avoidance
by: R. Roesler, et al.
Published: (2000-07-01)

Lonely in the Dark: Trauma Memory and Sex‐Specific Dysregulation of Amygdala Reactivity to Fear Signals
by: Mitjan Morr, et al.
Published: (2022-05-01)

The identities of insulin signaling pathway are affected by overexpression of Tau and its phosphorylation form
by: Ningtian Ma, et al.
Published: (2022-12-01)

Oxidative Stress Modifies the Levels and Phosphorylation State of Tau Protein in Human Fibroblasts
by: Alejandro Ibáñez-Salazar, et al.
Published: (2017-09-01)

Phosphorylated Tau 181 Serum Levels Predict Alzheimer’s Disease in the Preclinical Stage
by: Wei Qin, et al.
Published: (2022-06-01)

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
by: Priyanka Rawat, et al.
Published: (2022-10-01)

Molecular diversity and functional dynamics in the central amygdala
by: Li-Feng Yeh, et al.
Published: (2024-02-01)

MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology
by: Chihiro Sato, et al.
Published: (2021-09-01)

Histone H3 Ser57 and Thr58 phosphorylation in the brain of 5XFAD mice
by: Kyle W. Anderson, et al.
Published: (2015-01-01)

Nicotinamide mononucleotide adenylyltransferase uses its NAD+ substrate-binding site to chaperone phosphorylated Tau
by: Xiaojuan Ma, et al.
Published: (2020-04-01)

Constant Levels of Tau Phosphorylation in the Brain of htau Mice
by: Joerg Neddens, et al.
Published: (2020-08-01)

Research progress on fear of dementia
by: Long Xiang, et al.
Published: (2022-10-01)